Sectors
KPTI
Karyopharm Therapeutics Inc.
2.06
1 x 1.73
1 x 2.27
bid
ask
+
0.19
10.16%
1 @ 07:59 PM
2.07 +0.01 (0.49%)
| Ytd | -72.01% | |
| 1y | -71.03% |
1.79
day range
2.14
1.79
52 week range
10.99
| Open | 1.90 | Prev Close | 1.87 | Low | 1.79 | High | 2.14 | Mkt Cap | 46.72M |
| Vol | 2.03M | Avg Vol | 1.28M | EPS | -14.33 | P/E | N/A | Forward P/E | -0.87 |
| Beta | 0.15 | Short Ratio | 19.48 | Inst. Own | 48.24% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 6.02 | 200-d Avg | 7.23 | 1yr Est | 4.50 |
| Income Statement | |||
| Total Revenue | 33.43M | ||
| Revenues (USD) | 33.43M | ||
| Cost of Revenue | 1.09M | ||
| Gross Profit | 32.35M | ||
| Operating Expenses | 54.87M | ||
| Research and Development Expense | 28.96M | ||
| Selling, General and Administrative Expense | 25.92M | ||
| Operating Income | -22.53M | ||
| Interest Expense | 13.14M | ||
| Net Income | -67.02M | ||
| Net Income Common Stock | -67.02M | ||
| Net Income Common Stock (USD) | -67.02M | ||
| Consolidated Income | -67.02M | ||
| Earnings per Basic Share | -2.32 | ||
| Earnings per Basic Share (USD) | -2.32 | ||
| Earnings per Diluted Share | -2.32 | ||
| Earning Before Interest & Taxes (EBIT) | -53.88M | ||
| Earning Before Interest & Taxes (USD) | -53.88M | ||
| Weighted Average Shares | 28.94M | ||
| Weighted Average Shares Diluted | 28.94M | ||
| Balance Sheet | |||
| Cash and Equivalents | 55.30M | ||
| Cash and Equivalents (USD) | 55.30M | ||
| Investments | 10.13M | ||
| Investments Current | 10.13M | ||
| Trade and Non-Trade Receivables | 29.87M | ||
| Current Assets | 106.38M | ||
| Property, Plant & Equipment Net | 4.35M | ||
| Total Assets | 111.32M | ||
| Debt Current | 41.38M | ||
| Total Debt | 256.19M | ||
| Current Liabilities | 134.23M | ||
| Debt Non-Current | 214.82M | ||
| Total Liabilities | 441.49M | ||
| Accumulated Retained Earnings (Deficit) | -1.85B | ||
| Accumulated Other Comprehensive Income | 41.00K | ||
| Shareholders Equity | -330.17M | ||
| Shareholders Equity (USD) | -330.17M | ||
| Assets Non-Current | 4.94M | ||
| Total Debt (USD) | 256.19M | ||
| Inventory | 3.99M | ||
| Liabilities Non-Current | 307.25M | ||
| Trade and Non-Trade Payables | 7.66M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | -3.00K | ||
| Net Cash Flow from Financing | -898.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -35.87M | ||
| Issuance (Purchase) of Equity Shares | -898.00K | ||
| Net Cash Flow from Investing | -10.04M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -10.04M | ||
| Net Cash Flow from Operations | -24.93M | ||
| Effect of Exchange Rate Changes on Cash | -4.00K | ||
| Share Based Compensation | 1.93M | ||